185 related articles for article (PubMed ID: 34915638)
21. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
[TBL] [Abstract][Full Text] [Related]
22. Unbalanced bidirectional causal association between thyroid cancer and ER-positive breast cancer: should we recommend screening for thyroid cancer in breast cancer patients?
Wang H; Li S; Shi J; Feng C; Wang Y; Zhang F
BMC Genomics; 2023 Dec; 24(1):762. PubMed ID: 38082224
[TBL] [Abstract][Full Text] [Related]
23. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
24. [Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].
Wang LZ; Li JF; Wang TF; Xie YT; Fan ZQ; He YJ; Ouyang T
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):127-133. PubMed ID: 33378805
[No Abstract] [Full Text] [Related]
25. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma.
Huang H; Liu S; Xu Z; Ni S; Zhang Z; Wang X
Medicine (Baltimore); 2017 Jul; 96(27):e7461. PubMed ID: 28682915
[TBL] [Abstract][Full Text] [Related]
27. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
28. The clinical and genetic features in patients coexisting primary breast and thyroid cancers.
Fu J; He M; Wu Q; Zhang X; Qi X; Shen K; Wang X; Zhang G
Front Endocrinol (Lausanne); 2023; 14():1136120. PubMed ID: 37229458
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
30. Hepatosteatosis may predict late recurrence of breast cancer: A single-center observational study.
Kus T; Cinkir HY; Aktas G; Abali H
Curr Probl Cancer; 2019 Dec; 43(6):100461. PubMed ID: 30686567
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
32. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.
Parl FF; Schmidt BP; Dupont WD; Wagner RK
Cancer; 1984 Nov; 54(10):2237-42. PubMed ID: 6488142
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
35. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
[TBL] [Abstract][Full Text] [Related]
36. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
38. A Possible Association Between Thyroid Cancer and Breast Cancer.
An JH; Hwangbo Y; Ahn HY; Keam B; Lee KE; Han W; Park DJ; Park IA; Noh DY; Youn YK; Cho BY; Im SA; Park YJ
Thyroid; 2015 Dec; 25(12):1330-8. PubMed ID: 26442580
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features and risk factors for recurrence in mucinous breast cancer].
Lei L; Chen ZZ; Zheng YB; Chen B; Wang X; Wang XJ
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):274-279. PubMed ID: 28550667
[No Abstract] [Full Text] [Related]
40. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
Willner J; Kiricuta IC; Kölbl O
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
